Latest Breaking News On - Health canada controlled drugs - Page 1 : vimarsana.com

PurMinds NeuroPharma Selected to Present at the 2024 OBIO Investment Summit

PurMinds NeuroPharma Selected to Present at the 2024 OBIO Investment Summit
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesJanet qiStefan klotterAmy reicheltKristina spionjakAlan kozikowskiPurminds neuropharmaHealth canada controlled drugsPurminds neuropharma incMassachusetts newsfile corpMinds neuropharmaInvestment summitChief scientific officerChief innovation officerOntario neurolabProduction facility

Optimi Health Secures Amendment to Increase Quantities Of MDMA, MDA, And 2C-B Under Controlled Drugs And Substances Dealer s Licence

Optimi Health Secures Amendment to Increase Quantities Of MDMA, MDA, And 2C-B Under Controlled Drugs And Substances Dealer s Licence
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomBritish columbiaMichael kyddOptimi health corpDrug administrationHealth canada controlled drugsCompany annual information formHealth canadaAnnual reviewDrug master fileDrug establishment licenceAnnual information form

Optimi Health Secures Amendment to Increase Quantities Of MDMA, MDA, And 2C-B Under Controlled Drugs And Substances Dealer s Licence -January 19, 2024 at 07:31 am EST

Strategic licensing plan prepares Company for future regulatory approvalsVANCOUVER, British Columbia, Jan. 19, 2024 Optimi Health Corp. , a Health Canada licensed drug researcher and.

British columbiaUnited kingdomMichael kyddCompany annual information formHealth canada controlled drugsHealth canadaDrug administrationOptimi health corpAnnual reviewDrug master fileDrug establishment licenceAnnual information form

PurMinds NeuroPharma: PurMinds Announces Its Attendance at the 42nd Annual J P Morgan Healthcare Meeting in San Francisco

PurMinds NeuroPharma: PurMinds Announces Its Attendance at the 42nd Annual J P Morgan Healthcare Meeting in San Francisco
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoKristina spionjakAlan kozikowskiPurminds neuropharmaJanet qiStefan klotterMassachusetts newsfile corpHealth canada controlled drugsMinds neuropharmaChief scientific officerHealthcare meetingOntario neurolabProduction facilityCanada controlled drugsSubstances dealer

PurMinds Announces Its Attendance at the 42nd Annual J P Morgan Healthcare Meeting in San Francisco

Toronto, Ontario and Boston, Massachusetts (Newsfile Corp. - December 14, 2023) - PurMinds NeuroPharma ("PurMinds™" or the "Company"), a clinical-stage neuroscience company focused on neurological and neurodegenerative disorders and advancing a robust clinical development pipeline of small molecules, psychedelic compounds and other modalities, is pleased to announce that its management team, including Chief Executive Officer Janet Qi and Chief Scientific Officer Dr. Alan Kozikowski, will be att

United statesSan franciscoPurminds neuropharmaKristina spionjakAlan kozikowskiJanet qiMassachusetts newsfile corpHealth canada controlled drugsMinds neuropharmaChief scientific officerHealthcare meetingOntario neurolabProduction facilityCanada controlled drugsSubstances dealerNeurodegenerative disorders